Related Experiment Video
Updated: Feb 11, 2026

Primer-Free Aptamer Selection Using A Random DNA Library
Published on: July 26, 2010
Nonspecific amplification of human DNA by Streptococcus pneumoniae LytA primer
Helen Hencida Thangamony1, Ravindran Kumar1, Chinnappan Palaniappan Thangavelu1
1Division of Molecular Diagnostics, Microbiological Laboratory, 12A Cowley Brown Road, R.S.Puram, Coimbatore, Tamil Nadu, India.
Background:
Determination of various analytical parameters is essential for the validation of primers used for in-house nucleic acid amplification tests. While standardising a high-resolution melt analysis (HRMA) for detection of Streptococcus pneumoniae in acute pyogenic meningitis, we encountered non-specific amplification of certain base pair sequences of human DNA by Centers for Disease Control & Prevention, USA recommended S. pneumoniae LytA primer.
Materials And Methods:
HRMA was standardised using DNA extracted from an ATCC strain of S. pneumoniae using SP LytA F373 primer and Type-it HRMTM polymerase chain reaction kit in Rotor-Gene Q Thermal Cycler according to the manufacturer's instructions. Specificity of the primers was determined in dry and wet laboratory experiments against diverse related and unrelated microbial pathogens by HRMA and on DNA extracted from unspiked clinical samples negative for SP DNA. Sensitivity was determined by calculating lower limit of detection threshold in experiments with spiked samples. The amplicon from spiked experiments was sequenced and analysed through Gene Bank.
Results:
Our dry/wet laboratory experiments showed two separate curves and different Tm values indicating certain non-specific amplification by the primer. Basic Local Alignment Search Tool (BLAST) analysis of the amplicon obtained in the spiked experiment showed sequences of human chromosome 20 associated with Homo sapiens protein tyrosine phosphatase, receptor type T gene. The problem was resolved by stopping the reaction at 30th Ct cycle and observing the Tm values.
Conclusion:
Since HRMA is done without a specific probe, one should be aware of non-specific amplifications while using primers for HRMA of human clinical samples.
Insights
High-resolution melt analysis (HRMA) for Streptococcus pneumoniae detection can show non-specific amplification of human DNA. Adjusting the cycle threshold resolved this issue, ensuring accurate results for meningitis diagnostics.
Area of Science:
- Molecular Diagnostics
- Microbiology
Background:
- Primer validation is crucial for in-house nucleic acid amplification tests.
- Standardizing high-resolution melt analysis (HRMA) for Streptococcus pneumoniae detection revealed non-specific human DNA amplification.
Purpose of the Study:
- To standardize HRMA for Streptococcus pneumoniae detection.
- To investigate and resolve non-specific amplification issues.
Main Methods:
- HRMA was performed using S. pneumoniae DNA and specific primers.
- Primer specificity was tested against various pathogens and human DNA.
- Amplicon sequencing and Basic Local Alignment Search Tool (BLAST) analysis were conducted.
Main Results:
- Non-specific amplification of human DNA sequences was observed.
- BLAST analysis identified human chromosome 20 sequences.
- Stopping the reaction at the 30th Ct cycle resolved the non-specific amplification.
Conclusions:
- Awareness of potential non-specific amplification is essential when using HRMA with human clinical samples.
- Primer selection and reaction optimization are critical for accurate diagnostic tests.
Related Concept Videos
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
DNA Replication
Replication in Prokaryotes
DNA replication...
Complementary DNA
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

